Healthcare -
Medical - Healthcare Information Services - NASDAQ - US
$ 12.08
-2.58 %
$ 277 M
Market Cap
11.62
P/E
1. INTRINSIC VALUE
Balance Sheet
National Research Corporation
| Current Assets | 19.6 M |
| Cash & Short-Term Investments | 4.23 M |
| Receivables | 11.2 M |
| Other Current Assets | 4.17 M |
| Non-Current Assets | 113 M |
| Long-Term Investments | 0 |
| PP&E | 39.9 M |
| Other Non-Current Assets | 73 M |
| Current Liabilities | 35.9 M |
| Accounts Payable | 1.19 M |
| Short-Term Debt | 4.79 M |
| Other Current Liabilities | 29.9 M |
| Non-Current Liabilities | 65.4 M |
| Long-Term Debt | 57.9 M |
| Other Non-Current Liabilities | 7.5 M |
EFFICIENCY
Earnings Waterfall
National Research Corporation
| Revenue | 143 M |
| Cost Of Revenue | 56.9 M |
| Gross Profit | 86.1 M |
| Operating Expenses | 50.9 M |
| Operating Income | 35.2 M |
| Other Expenses | 10.4 M |
| Net Income | 24.8 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
National Research Corporation
| Net Income | 24.8 M |
| Depreciation & Amortization | 6.02 M |
| Capital Expenditures | -15.4 M |
| Stock-Based Compensation | 284 K |
| Change in Working Capital | 3.84 M |
| Others | 2.29 M |
| Free Cash Flow | 19.2 M |
Wall Street Analysts Price Targets
National Research Corporation
NRC has no price targets from Wall Street.
4. DIVIDEND
ANALYSIS
0.67%
DIVIDEND YIELD
0.12 USD
DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership
National Research Corporation
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
National Research Corporation Declares Quarterly Dividend
LINCOLN, Neb.--(BUSINESS WIRE)--National Research Corporation, dba NRC Health, (NASDAQ: NRC) announced that its Board of Directors has declared a quarterly cash dividend of $0.12 (twelve cents) per share payable Friday, April 11, 2025, to shareholders of record as of the close of business on Friday, March 28, 2025. For more than 40 years, NRC Health (NASDAQ: NRC) has led the charge to humanize healthcare and support organizations in their understanding of each unique individual. NRC Health's co.
businesswire.com
- 3 weeks ago
Amazon-Owned One Medical CEO Trent Green to Move to NRC Health
The CEO of Amazon-owned One Medical, Trent Green, will leave that position to become CEO of National Research Corporation, a publicly traded provider of healthcare solutions doing business as NRC Health. NRC Health announced the move in a Wednesday (March 5) press release, saying Green will join the company June 1.
pymnts.com
- 1 month ago
UofL Health Chooses NRC Health to Elevate Patient and Employee Experience Initiatives
LOUISVILLE, Ky.--(BUSINESS WIRE)-- #EmployeeExperience--UofL Health selects NRC Health to elevate patient and employee experience across its health system.
businesswire.com
- 1 month ago
NRC Health ranked #1 Best in KLAS for Healthcare Experience Management
LINCOLN, Neb.--(BUSINESS WIRE)-- #BIK--NRC Health, a leader in advanced technology and data-driven insights to deliver Human Understanding across the healthcare ecosystem, has proudly announced its recognition as the recipient of the esteemed 2025 Best in KLAS Award for Healthcare Experience Management for the second time in three years. This award once again underscores NRC Health's relentless pursuit of excellence in healthcare experience management through innovation and deep partnerships, in which.
businesswire.com
- 2 months ago
National Research's Q4 Earnings Drop Y/Y, Stock Falls 9%
NRC's Q4 EPS drops to 28 cents despite revenue growth, hit by rising costs and higher interest expenses.
zacks.com
- 2 months ago
National Research Corporation Announces Fourth Quarter Results
LINCOLN, Neb.--(BUSINESS WIRE)--National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the fourth quarter 2024 and other corporate developments. Financial Results Revenue for the quarter was approximately $36.9 million compared with approximately $38.0 million in the 2023 quarter. Earnings per diluted share were $0.28 compared with $0.36 for the 2023 quarter. At December 31, 2024, the Company's net indebtedness (total borrowing minus cash and cash equivalents) w.
businesswire.com
- 2 months ago
BTQ Technologies Announces Funding from National Research Council of Canada Industrial Research Assistance Program (NRC IRAP)
Funding: BTQ Technologies will receive funding of up to $150,000 from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP). This funding will enhance BTQ's IP portfolio, contributing to the company's R&D efforts.
prnewswire.com
- 3 months ago
Zacks Initiates Coverage of NRC Health With Neutral Recommendation
Discover why Zacks has given NRC Health a "Neutral" rating, being the first on Wall Street to initiate coverage on the stock. Dive into the company's AI innovations, strategic partnerships, and financial resilience, along with the challenges of revenue declines, rising debt and stiff competition.
zacks.com
- 4 months ago
Signature Healthcare Elevates Patient Experience and Workforce Engagement Through Strategic Partnership With NRC Health
LINCOLN, Neb.--(BUSINESS WIRE)-- #HealthcareInnovation--Signature Healthcare has selected NRC Health to enhance its network through human-centered healthcare solutions and data-driven insights.
businesswire.com
- 4 months ago
National Research Corporation Announces Third Quarter Results
LINCOLN, Neb.--(BUSINESS WIRE)--National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the third quarter 2024 and other corporate developments. Financial Results Revenue for the quarter was approximately $35.8 million compared with approximately $37.9 million in the 2023 quarter. Earnings per diluted share were $0.24 compared with $0.32 for the 2023 quarter. At September 30, 2024, the Company's net indebtedness (total borrowing minus cash and cash equivalents) w.
businesswire.com
- 5 months ago
National Research Corporation Announces Second Quarter Results
LINCOLN, Neb.--(BUSINESS WIRE)--National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the second quarter 2024 and several other corporate developments. Financial Results Revenue for the quarter was approximately $35 million compared with approximately $36 million in the 2023 quarter. Earnings per diluted share were $0.26 compared with $0.29 for the 2023 quarter. At June 30, 2024, the Company's net indebtedness (total borrowing minus cash and cash equivalents) w.
businesswire.com
- 8 months ago
NANO Nuclear Energy Appoints Distinguished Nuclear Regulatory Expert David Tiktinsky as Head of Nuclear Regulatory Licensing after nearly 40-years with the Nuclear Regulatory Commission (NRC)
Tiktinsky's nearly 40 years of experience at the U.S. Nuclear Regulatory Commission to greatly assist NANO Nuclear in navigating the complex U.S. nuclear licensing process
globenewswire.com
- 8 months ago
8. Profile
Summary
National Research Corporation NRC
COUNTRY
US
INDUSTRY
Medical - Healthcare Information Services
MARKET CAP
$ 277 M
Dividend Yield
0.67%
Description
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. Further, the company offers health risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs; and transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction and support safe care transitions. Additionally, it provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems, post-acute providers, and payer organizations. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.
Contact
1245 Q Street, Lincoln, NE, 68508
https://nrchealth.com
IPO
Date
May 23, 2013
Employees
368
Officers
Megan Charko
Senior Manager of Content Marketing
Mr. Michael D. Hays
Founder, Chief Executive Officer, President & Director
Ms. Helen L. Hrdy
Chief Operating Officer